2C-O-4:
741 ·
782
Shulgin, AT. Basic Pharmacology and Effects. In Hallucinogens. A Forensic Drug Handbook; Laing, R; Siegel, JA, Eds., Academic Press, London, 24 Apr 2003; pp 67–137. 6.3 MB.
Jacob, P; Shulgin, AT. Structure-activity relationships of the classic hallucinogens and their analogs. In Hallucinogens: An update. NIDA Research Monograph 146; Lin, GC; Glennon, RA, Eds., U.S. Department of Health and Human Services, National Institute of Health, U.S. Government Printing Office, Washington, DC, 1 Jan 1994; pp 74–91. 51 kB.
Kolaczynska, KE; Luethi, D; Trachsel, D; Hoener, MC; Liechti, ME. Receptor interaction profiles of 4-alkoxy-substituted 2,5-dimethoxyphenethylamines and related amphetamines. Front. Pharmacol., 28 Nov 2019, 10 (1423). 1.5 MB. https://doi.org/10.3389/fphar.2019.01423 #22
Clancy, L; Philp, M; Shimmon, R; Fu, S. Development and validation of a color spot test method for the presumptive detection of 25-NBOMe compounds. Drug Test. Anal., 19 Aug 2020, 13 (5), 929-943. 11.3 MB. https://doi.org/10.1002/dta.2905 #4-isopropoxy-2,5-dimethoxyphenet
N-Me-TMA-2 · METHYL-TMA-2
N-Me-TMA-6 · METHYL-TMA-6
N,N-Me-β,3,4-TMPEA · β,3,4-Trimethoxy-N,N-dimethylphenethylamine
3,4-Dimethoxy-5-methoxymethylamphetamine · 3-homo-TMA